Literature DB >> 9559775

Antibiotic-induced lipopolysaccharide (LPS) release from Salmonella typhi: delay between killing by ceftazidime and imipenem and release of LPS.

P van Langevelde1, K M Kwappenberg, P H Groeneveld, H Mattie, J T van Dissel.   

Abstract

It has been suggested that the antibiotic-induced release of lipopolysaccharide (LPS) is an important cause of the development of septic shock in patients treated for severe infections caused by gram-negative bacteria. Beta-lactam antibiotics change the integrity of the bacterial cell envelope by binding to penicillin-binding proteins (PBP) in the membrane and thus may affect the amount of LPS that is released and the kinetics of that release. In this respect, ceftazidime at intermediate concentrations binds with a high affinity to PBP 3 and PBP 1a and thus can induce filament formation in addition to killing, whereas imipenem preferentially binds to PBP 2 and PBP 1b, leading to spheroplast formation and rapid cell lysis. We investigated the effects of these antibiotics on the killing and the release of the radioactively labelled LPS of Salmonella typhi Ty 21A. A mathematical model was developed to calculate the delay between bacterial killing and LPS release, designated the lag time. At antibiotic concentrations inducing equal killing, the amount of LPS released was the same for both antibiotics. Only after 6 h of incubation at antibiotic concentrations above 0.5 microg/ml, the amount of 3H-LPS released was slightly higher (approximately 1.2-fold) in incubations with ceftazidime than in those with imipenem, and the maximum releases of the total label were 33.2% +/- 0.89% and 27.1% +/- 0.45%, respectively. Despite the clear concentration-dependent effect on the bacterial killing and subsequent LPS release, the lag time was independent of the antibiotic concentration. For ceftazidime as well as imipenem the lag time amounted to approximately 60 min. In conclusion, our findings imply that the mechanism of antibiotic-induced LPS release is independent of the PBP affinities for these beta-lactam antibiotics. Furthermore, once the organism is killed by either imipenem or ceftazidime, the rate of LPS release from S. typhi does not differ according to the antibiotic with which the organism is killed, and there is little difference in the relative amount of LPS released.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9559775      PMCID: PMC105534          DOI: 10.1128/AAC.42.4.739

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  [Accidents in the treatment of typhoid fever with chloromycetin; experimental study and therapeutic deductions].

Authors:  J REILLY; A COMPAGNON; P TOURNIER; R BASTIN; H DU BUIT
Journal:  Bull Mem Soc Med Hop Paris       Date:  1950

2.  Serial quantitation of endotoxemia and bacteremia during therapy for gram-negative bacterial sepsis.

Authors:  J L Shenep; P M Flynn; F F Barrett; G L Stidham; D F Westenkirchner
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

3.  Release of 51Cr-endotoxin from bacteria as an assay of serum bactericidal activity.

Authors:  J Fierer; F Finley; A I Braude
Journal:  J Immunol       Date:  1974-06       Impact factor: 5.422

4.  Frapper fort ou frapper doucement: a gram-negative dilemma.

Authors:  D A Hopkin
Journal:  Lancet       Date:  1978-12-02       Impact factor: 79.321

5.  In vitro-in vivo correlation, a time scaling problem? Evaluation of mean times.

Authors:  D Brockmeier
Journal:  Arzneimittelforschung       Date:  1984

6.  Relation of structural properties of beta-lactam antibiotics to antibacterial activity.

Authors:  H C Neu
Journal:  Am J Med       Date:  1985-08-09       Impact factor: 4.965

7.  Influence of subinhibitory concentrations of antibiotics on opsonization and phagocytosis of Pseudomonas aeruginosa by human polymorphonuclear leukocytes.

Authors:  D Milatovic
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

8.  The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.

Authors:  V L Tesh; R L Duncan; D C Morrison
Journal:  J Immunol       Date:  1986-08-15       Impact factor: 5.422

9.  Modulation of bacteriolysis by cooperative effects of penicillin-binding proteins 1a and 3 in Escherichia coli.

Authors:  E Tuomanen; K Gilbert; A Tomasz
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

10.  Detection of circulating tumor necrosis factor after endotoxin administration.

Authors:  H R Michie; K R Manogue; D R Spriggs; A Revhaug; S O'Dwyer; C A Dinarello; A Cerami; S M Wolff; D W Wilmore
Journal:  N Engl J Med       Date:  1988-06-09       Impact factor: 91.245

View more
  21 in total

1.  Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection.

Authors:  H L Rocchetta; C J Boylan; J W Foley; P W Iversen; D L LeTourneau; C L McMillian; P R Contag; D E Jenkins; T R Parr
Journal:  Antimicrob Agents Chemother       Date:  2001-01       Impact factor: 5.191

2.  Preparation of immunoglobulin Y (IgY) against lipopolysaccharide using gel chromatography from the yolks of eggs laid by immunized hens.

Authors:  Siyuan Ma; Yaping Zhang
Journal:  Protein J       Date:  2010-10       Impact factor: 2.371

3.  Optimization of airborne endotoxin exposure assessment: effects of filter type, transport conditions, extraction solutions, and storage of samples and extracts.

Authors:  Suzanne Spaan; Dick J J Heederik; Peter S Thorne; Inge M Wouters
Journal:  Appl Environ Microbiol       Date:  2007-08-03       Impact factor: 4.792

Review 4.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

5.  A Lactobacillus acidophilus strain of human gastrointestinal microbiota origin elicits killing of enterovirulent Salmonella enterica Serovar Typhimurium by triggering lethal bacterial membrane damage.

Authors:  Marie-Hélène Coconnier-Polter; Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

6.  High therapeutic index of factor C Sushi peptides: potent antimicrobials against Pseudomonas aeruginosa.

Authors:  Y H Yau; B Ho; N S Tan; M L Ng; J L Ding
Journal:  Antimicrob Agents Chemother       Date:  2001-10       Impact factor: 5.191

Review 7.  Outer Membrane Lipid Secretion and the Innate Immune Response to Gram-Negative Bacteria.

Authors:  Nicole P Giordano; Melina B Cian; Zachary D Dalebroux
Journal:  Infect Immun       Date:  2020-06-22       Impact factor: 3.441

Review 8.  Modulation of release of proinflammatory bacterial compounds by antibacterials: potential impact on course of inflammation and outcome in sepsis and meningitis.

Authors:  Roland Nau; Helmut Eiffert
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

9.  Differential tumor necrosis factor alpha expression and release from peritoneal mouse macrophages in vitro in response to proliferating gram-positive versus gram-negative bacteria.

Authors:  W Cui; D C Morrison; R Silverstein
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

10.  Modulation of inflammatory response of wounds by antimicrobial photodynamic therapy.

Authors:  Khageswar Sahu; Mrinalini Sharma; Pradeep Kumar Gupta
Journal:  Laser Ther       Date:  2015-10-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.